• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种适用于初始评分为零的亚洲人群亚临床冠状动脉钙化进展的基于套索回归的风险模型。

A LASSO-Derived Risk Model for Subclinical CAC Progression in Asian Population With an Initial Score of Zero.

作者信息

Wu Yun-Ju, Mar Guang-Yuan, Wu Ming-Ting, Wu Fu-Zong

机构信息

Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

Department of Health Care Administration, Chang Jung Christian University, Tainan, Taiwan.

出版信息

Front Cardiovasc Med. 2021 Jan 15;7:619798. doi: 10.3389/fcvm.2020.619798. eCollection 2020.

DOI:10.3389/fcvm.2020.619798
PMID:33521068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7843450/
Abstract

This study is aimed at developing a prediction nomogram for subclinical coronary atherosclerosis in an Asian population with baseline zero score, and to compare its discriminatory ability with Framingham risk score (FRS) and atherosclerotic cardiovascular disease (ASCVD) models. Clinical characteristics, physical examination, and laboratory profiles of 830 subjects were retrospectively reviewed. Subclinical coronary atherosclerosis in term of Coronary artery calcification (CAC) progression was the primary endpoint. A nomogram was established based on a least absolute shrinkage and selection operator (LASSO)-derived logistic model. The discrimination and calibration ability of this nomogram was evaluated by Hosmer-Lemeshow test and calibration curves in the training and validation cohort. Of the 830 subjects with baseline zero score with the average follow-up period of 4.55 ± 2.42 year in the study, these subjects were randomly placed into the training set or validation set at a ratio of 2.8:1. These study results showed in the 612 subjects with baseline zero score, 145 (23.69%) subjects developed CAC progression in the training cohort ( = 612), while in the validation cohort ( = 218), 51 (23.39%) subjects developed CAC progression. This LASSO-derived nomogram included the following 10 predictors: "sex," age," "hypertension," "smoking habit," "Gamma-Glutamyl Transferase (GGT)," "C-reactive protein (CRP)," "high-density lipoprotein cholesterol (HDL-C)," "cholesterol," "waist circumference," and "follow-up period." Compared with the FRS and ASCVD models, this LASSO-derived nomogram had higher diagnostic performance and lower Akaike information criterion (AIC) and Bayesian information criterion (BIC) value. The discriminative ability, as determined by the area under receiver operating characteristic curve was 0.780 (95% confidence interval: 0.731-0.829) in the training cohort and 0.836 (95% confidence interval: 0.761-0.911) in the validation cohort. Moreover, satisfactory calibration was confirmed by Hosmer-Lemeshow test with -values of 0.654 and 0.979 in the training cohort and validation cohort. This validated nomogram provided a useful predictive value for subclinical coronary atherosclerosis in subjects with baseline zero score, and could provide clinicians and patients with the primary preventive strategies timely in individual-based preventive cardiology.

摘要

本研究旨在为基线评分为零的亚洲人群开发一种预测亚临床冠状动脉粥样硬化的列线图,并将其鉴别能力与弗雷明汉风险评分(FRS)和动脉粥样硬化性心血管疾病(ASCVD)模型进行比较。回顾性分析了830名受试者的临床特征、体格检查和实验室检查结果。以冠状动脉钙化(CAC)进展来定义的亚临床冠状动脉粥样硬化为主要终点。基于最小绝对收缩和选择算子(LASSO)推导的逻辑模型建立了列线图。通过Hosmer-Lemeshow检验和校准曲线在训练队列和验证队列中评估该列线图的鉴别能力和校准能力。在本研究中,830名基线评分为零的受试者平均随访期为4.55±2.42年,这些受试者以2.8:1的比例随机分为训练集或验证集。这些研究结果显示,在612名基线评分为零的受试者中,训练队列(n = 612)中有145名(23.69%)受试者出现CAC进展,而在验证队列(n = 218)中,有51名(23.39%)受试者出现CAC进展。这种基于LASSO推导的列线图包括以下10个预测因子:“性别”、“年龄”、“高血压”、“吸烟习惯”、“γ-谷氨酰转移酶(GGT)”、“C反应蛋白(CRP)”、“高密度脂蛋白胆固醇(HDL-C)”、“胆固醇”、“腰围”和“随访期”。与FRS和ASCVD模型相比,这种基于LASSO推导的列线图具有更高的诊断性能以及更低的赤池信息准则(AIC)和贝叶斯信息准则(BIC)值。在训练队列中,由受试者工作特征曲线下面积确定的鉴别能力为0.780(95%置信区间:0.731 - 0.829),在验证队列中为0.836(95%置信区间:0.761 - 0.911)。此外,Hosmer-Lemeshow检验在训练队列和验证队列中的P值分别为0.654和0.979,证实了校准效果良好。这种经过验证的列线图为基线评分为零的受试者的亚临床冠状动脉粥样硬化提供了有用的预测价值,并可为临床医生和患者在基于个体的预防心脏病学中及时提供一级预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/b65b75cd0883/fcvm-07-619798-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/8d8b11f56568/fcvm-07-619798-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/2cc7b67f73e0/fcvm-07-619798-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/2d17d37555be/fcvm-07-619798-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/b65b75cd0883/fcvm-07-619798-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/8d8b11f56568/fcvm-07-619798-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/2cc7b67f73e0/fcvm-07-619798-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/2d17d37555be/fcvm-07-619798-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/7843450/b65b75cd0883/fcvm-07-619798-g0004.jpg

相似文献

1
A LASSO-Derived Risk Model for Subclinical CAC Progression in Asian Population With an Initial Score of Zero.一种适用于初始评分为零的亚洲人群亚临床冠状动脉钙化进展的基于套索回归的风险模型。
Front Cardiovasc Med. 2021 Jan 15;7:619798. doi: 10.3389/fcvm.2020.619798. eCollection 2020.
2
Natural course of coronary artery calcium progression in Asian population with an initial score of zero.亚洲人群初始评分为零的冠状动脉钙进展的自然病程。
BMC Cardiovasc Disord. 2020 May 6;20(1):212. doi: 10.1186/s12872-020-01498-x.
3
The Serum NLRP1 Level and Coronary Artery Calcification: From Association to Development of a Risk-Prediction Nomogram.血清NLRP1水平与冠状动脉钙化:从关联到风险预测列线图的构建
Rev Cardiovasc Med. 2024 Jul 16;25(7):265. doi: 10.31083/j.rcm2507265. eCollection 2024 Jul.
4
Machine learning derived ECG risk score improves cardiovascular risk assessment in conjunction with coronary artery calcium scoring.机器学习得出的心电图风险评分与冠状动脉钙化评分相结合可改善心血管风险评估。
Front Cardiovasc Med. 2022 Oct 5;9:976769. doi: 10.3389/fcvm.2022.976769. eCollection 2022.
5
Development and validation of a risk prediction model for aspiration in patients with acute ischemic stroke.开发和验证急性缺血性脑卒中患者吸入风险预测模型。
J Clin Neurosci. 2024 Jun;124:60-66. doi: 10.1016/j.jocn.2024.04.022. Epub 2024 Apr 22.
6
LASSO-derived nomogram predicting new-onset diabetes mellitus in patients with kidney disease receiving immunosuppressive drugs.基于 LASSO 算法的列线图预测接受免疫抑制剂治疗的肾脏病患者新发糖尿病的风险。
J Clin Pharm Ther. 2022 Oct;47(10):1627-1635. doi: 10.1111/jcpt.13713. Epub 2022 Jul 5.
7
Nomogram model and risk score to predict 5-year risk of progression from prediabetes to diabetes in Chinese adults: Development and validation of a novel model.列线图模型和风险评分预测中国成年人从糖尿病前期进展为糖尿病的 5 年风险:一种新模型的开发和验证。
Diabetes Obes Metab. 2023 Mar;25(3):675-687. doi: 10.1111/dom.14910. Epub 2022 Dec 2.
8
The association of Framingham and Reynolds risk scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis).弗雷明汉风险评分和雷诺兹风险评分与 MESA(动脉粥样硬化多民族研究)中冠状动脉钙化的发生率和进展的相关性。
J Am Coll Cardiol. 2011 Nov 8;58(20):2076-83. doi: 10.1016/j.jacc.2011.08.022.
9
New look at the power of zero coronary artery calcium (CAC) in Asian population: a systemic review and meta-analysis.亚洲人群中冠状动脉钙化(CAC)为零的意义新视角:一项系统评价与荟萃分析
Cardiovasc Diagn Ther. 2024 Jun 30;14(3):377-387. doi: 10.21037/cdt-23-474. Epub 2024 May 30.
10
Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).载脂蛋白 B 与低密度脂蛋白胆固醇和非高密度脂蛋白胆固醇的不匹配与动脉粥样硬化多民族研究(MESA)中的冠状动脉钙化有关。
J Clin Lipidol. 2020 Jan-Feb;14(1):109-121.e5. doi: 10.1016/j.jacl.2019.11.005. Epub 2019 Nov 29.

引用本文的文献

1
A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease.一种基于套索算法推导的模型,用于预测动脉粥样硬化性心血管疾病患者使用前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂未达到低密度脂蛋白胆固醇(LDL-C)降低目标的情况。
Lipids Health Dis. 2025 Feb 21;24(1):65. doi: 10.1186/s12944-025-02488-8.
2
Establishment and validation of apnea risk prediction models in preterm infants: a retrospective case control study.早产儿呼吸暂停风险预测模型的建立与验证:一项回顾性病例对照研究。
BMC Pediatr. 2024 Oct 11;24(1):654. doi: 10.1186/s12887-024-05125-y.
3
New look at the power of zero coronary artery calcium (CAC) in Asian population: a systemic review and meta-analysis.

本文引用的文献

1
Subclinical atherosclerosis: how and when to treat it?亚临床动脉粥样硬化:如何治疗以及何时治疗?
Eur Heart J Suppl. 2020 Jun;22(Suppl E):E87-E90. doi: 10.1093/eurheartj/suaa068. Epub 2020 Mar 24.
2
Natural course of coronary artery calcium progression in Asian population with an initial score of zero.亚洲人群初始评分为零的冠状动脉钙进展的自然病程。
BMC Cardiovasc Disord. 2020 May 6;20(1):212. doi: 10.1186/s12872-020-01498-x.
3
Short-Term Progression of Multiterritorial Subclinical Atherosclerosis.多部位亚临床动脉粥样硬化的短期进展。
亚洲人群中冠状动脉钙化(CAC)为零的意义新视角:一项系统评价与荟萃分析
Cardiovasc Diagn Ther. 2024 Jun 30;14(3):377-387. doi: 10.21037/cdt-23-474. Epub 2024 May 30.
4
The association between C-reactive protein and coronary artery calcification: a systematic review and meta-analysis.C 反应蛋白与冠状动脉钙化的关系:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2024 Apr 10;24(1):204. doi: 10.1186/s12872-024-03856-5.
5
A LASSO-derived developing and validating risk model for chronic total occlusion in Asian population before coronary angiography.一种基于套索算法得出的、用于在冠状动脉造影术前对亚洲人群慢性完全闭塞进行风险评估模型的开发与验证
Cardiovasc Diagn Ther. 2023 Jun 30;13(3):496-508. doi: 10.21037/cdt-22-466. Epub 2023 May 10.
6
Predictors of long-term absence of coronary artery calcium in individuals with high blood pressure: results from the MESA study.高血压患者冠状动脉钙长期缺失的预测因素:来自 MESA 研究的结果。
Ann Med. 2023 Dec;55(1):2209334. doi: 10.1080/07853890.2023.2209334.
7
Comparing the pooled cohort equations and coronary artery calcium scores in a symptomatic mixed Asian cohort.在有症状的亚洲混合队列中比较汇总队列方程和冠状动脉钙化评分。
Front Cardiovasc Med. 2023 Jan 17;10:1059839. doi: 10.3389/fcvm.2023.1059839. eCollection 2023.
8
Assessing Agreement When Agreement Is Hard to Assess-The Agatston Score for Coronary Calcification.当一致性难以评估时评估一致性——冠状动脉钙化的阿加斯顿评分
Diagnostics (Basel). 2022 Nov 29;12(12):2993. doi: 10.3390/diagnostics12122993.
9
Intraindividual evaluation of effects of image filter function on image quality in coronary computed tomography angiography.冠状动脉计算机断层扫描血管造影中图像滤波功能对图像质量影响的个体内评估。
Front Cardiovasc Med. 2022 Sep 15;9:840735. doi: 10.3389/fcvm.2022.840735. eCollection 2022.
10
Fractal Geometry Illustrated Left Atrial Appendage Morphology That Predicted Thrombosis and Stroke in Patients With Atrial Fibrillation.分形几何阐明了预测房颤患者血栓形成和中风的左心耳形态。
Front Cardiovasc Med. 2022 May 10;9:779528. doi: 10.3389/fcvm.2022.779528. eCollection 2022.
J Am Coll Cardiol. 2020 Apr 14;75(14):1617-1627. doi: 10.1016/j.jacc.2020.02.026.
4
Evaluation of Coronary Artery Calcium Progression in Asymptomatic Individuals with an Initial Score of Zero.初始分数为零的无症状个体的冠状动脉钙化进展评估。
Korean Circ J. 2019 May;49(5):448-457. doi: 10.4070/kcj.2018.0318. Epub 2019 Feb 14.
5
Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring.他汀类药物对冠状动脉钙评分后心血管结局的影响。
J Am Coll Cardiol. 2018 Dec 25;72(25):3233-3242. doi: 10.1016/j.jacc.2018.09.051.
6
Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?亚临床动脉粥样硬化、心血管健康与疾病风险:心血管健康指数是否适用于一级预防人群?
BMC Public Health. 2018 Apr 2;18(1):429. doi: 10.1186/s12889-018-5263-6.
7
Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score.预测低危个体的亚临床动脉粥样硬化:理想心血管健康评分和 Fuster-BEWAT 评分。
J Am Coll Cardiol. 2017 Nov 14;70(20):2463-2473. doi: 10.1016/j.jacc.2017.09.032.
8
Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the HNR Study (Heinz Nixdorf Recall).冠状动脉钙化进展对冠状动脉和心血管事件风险预测的价值:HNR 研究(海因茨·尼克斯多夫回顾)的结果。
Circulation. 2018 Feb 13;137(7):665-679. doi: 10.1161/CIRCULATIONAHA.116.027034. Epub 2017 Nov 15.
9
Warranty Period of Zero Coronary Artery Calcium Score for Predicting All-Cause Mortality According to Cardiac Risk Burden in Asymptomatic Korean Adults.韩国无症状成年人中根据心脏风险负担预测全因死亡率的零冠状动脉钙化评分的质保期
Circ J. 2016 Oct 25;80(11):2356-2361. doi: 10.1253/circj.CJ-16-0731. Epub 2016 Oct 4.
10
CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology.CAD-RADS(商标名)冠状动脉疾病报告与数据系统。心血管计算机断层扫描学会(SCCT)、美国放射学会(ACR)和北美心血管影像学会(NASCI)的专家共识文件。经美国心脏病学会认可。
J Cardiovasc Comput Tomogr. 2016 Jul-Aug;10(4):269-81. doi: 10.1016/j.jcct.2016.04.005. Epub 2016 Jun 15.